| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 1 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 2 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 3 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 5 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Mood Stabilizer [EPC] | 3 | 0.0000 |
| 7 | Anti-epileptic Agent [EPC] | 3 | 0.0000 |
| 8 | Atypical Antipsychotic [EPC] | 6 | 0.0000 |
| 9 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 10 | Expectorant [EPC] | 2 | 0.0000 |
| 11 | Dihydropyridine Calcium Channel Blocker [EPC] | 1 | 0.0000 |
| 12 | Benzodiazepine [EPC] | 2 | 0.0000 |
| 13 | Insulin Analog [EPC] | 1 | 0.0000 |
| 14 | Corticosteroid [EPC] | 1 | 0.0000 |
| 15 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |